GRAIL, Inc. Common Stock
NASDAQ: GRALV0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Robert P. Ragusa
- Headquarters
- Menlo Park, United States
- Market cap
- $579.4M
- Website
- https://grail.com
Loading GRALV…
Loading profile data…Frequently asked questions about GRALV
What does GRAIL, Inc. Common Stock (GRALV) do?
GRAIL, LLC is a biotechnology firm dedicated to pioneering solutions for the early identification of cancer. The company offers Galleri, a multi-cancer early detection screening test designed for healthy individuals aged 50 and above who show no symptoms. Additionally, it provides DAC, a diagnostic assistance tool aimed at accelerating the diagn...
Where does GRALV trade?
GRAIL, Inc. Common Stock (GRALV) trades on the NASDAQ.
What sector is GRALV in?
GRAIL, Inc. Common Stock (GRALV) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of GRAIL, Inc. Common Stock?
Robert P. Ragusa is the chief executive officer of GRAIL, Inc. Common Stock (GRALV).
Where is GRAIL, Inc. Common Stock headquartered?
GRAIL, Inc. Common Stock is headquartered in United States.
Does GRALV pay a dividend?
GRAIL, Inc. Common Stock (GRALV) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.